Cingulate (CINGW) Shares Outstanding (Entity) (2021 - 2026)
Powered by 
Analysis
Cingulate (CINGW) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.70 Bn | 623.94 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 441.16 Bn | 434.59 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.48 Bn | 258.79 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.53 Bn | 45.15 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.20 Bn | 44.20 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.27 Bn | 20.74 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 13.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.89 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.98 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 586,313.00 |
| Mar 31, 2024 | 417,522.00 |
| Dec 31, 2023 | 75,432.00 |
| Sep 30, 2023 | 72,409.00 |
| Jun 30, 2023 | 50,235.00 |
| Mar 31, 2023 | 47,121.00 |
| Dec 31, 2022 | 47,121.00 |
| Sep 30, 2022 | 47,121.00 |
| Jun 30, 2022 | 47,121.00 |
| Mar 31, 2022 | 47,121.00 |
| Dec 31, 2021 | 30,889.00 |